Active ingredientYohimbine HydrochlorideCat. No. P-Y001-001CAS 65-19-0Family · Pharmaceutical analytical standards
Yohimbine
An indole alkaloid extracted from the bark of the yohimbe, a tree of western and central Africa, first isolated in 1896 by Adolph Spiegel. It blocks alpha-2 adrenergic receptors and in veterinary medicine is used to reverse xylazine sedation in dogs and deer. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?Its chemical structure was only worked out in 1943 by Bernhard Witkop, almost half a century after its isolation; the first total synthesis, in 23 steps, came in 1958 from Eugene van Tamelen.
Go to the active ingredient →Active ingredientYohimbine HydrochlorideCat. No. P-Y001-001CAS 65-19-0
Pharmacopoeial impurityYohimbine EP Impurity ACat. No. P-Y001-002CAS 549-84-8
Pharmacopoeial impurityYohimbine EP Impurity CCat. No. P-Y001-003CAS 483-10-3
Pharmacopoeial impurityYohimbine EP Impurity D(Pseudoyohimbine)Cat. No. P-Y001-004CAS 84-37-7
Pharmacopoeial impurityYohimbine EP Impurity E(Dihydrocorynantheine)Cat. No. P-Y001-005CAS 50439-68-4
Isotopically labelledYohimbine-13C-d3Cat. No. P-Y001-006CAS 1261254-59-4
Isotopically labelledYohimbine-d3Cat. No. P-Y001-007CAS 133146-00-6
ImpurityRauwolscine HClCat. No. P-Y001-008CAS 6211-32-1
ImpurityYohimbine beta-N-OxideCat. No. P-Y001-009CAS 70617-29-7
ImpurityYohimbinic AcidCat. No. P-Y001-010CAS 522-87-2No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Reference substanceYohimbine hydrochloride CRSEDQM code Y0000656Family YohimbineNeed a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.